Recent trends in the utilization of 'NSAIDs' in a tertiary care hospital

Indian Journal of Pharmacology

Volumn 35, Issue 5, 2003, Pages 318-319

  Jose, Vishnu M ^a   Thomas Antony, T ^b  

^a Department of Pharmacology   (India)

^b GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOROLAC; MEFENAMIC ACID; MELOXICAM; NABUMETONE; NAPROXEN; NIMESULIDE; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; ROFECOXIB;

DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG MARKETING; DRUG MEGADOSE; DRUG SAFETY; DRUG UTILIZATION; GASTROINTESTINAL TOXICITY; HOSPITAL CARE; HOSPITAL PHARMACY; HUMAN; INDIA; LETTER; LOW DRUG DOSE; MEDICAL AUDIT; MEDICAL INFORMATION SYSTEM; PRESCRIPTION; REHABILITATION CENTER; VALIDATION PROCESS;

EID: 0142011141     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Frolich JC. A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol Sci 1997;18:30-4.
2. Jones R. Efficacy and safety of COX 2 inhibitors. Br Med J 2002;325:607-8.
3. Malhotra S, Shafiq N, Pandhi P. Gastrointestinal adverse effects of COX-2 inhibitors. Gastroenterology Today 2002;6:130-2.
4. Juni P, Rutjes AWS, Dieppe PA. Are selective COX-2 inhibitors superior to traditional non-steroidal anti-inflammatory drugs? Br Med J 2002;324:1287-8.